Your browser doesn't support javascript.
loading
Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway.
Dabour, Mohamed S; Abdelgawad, Ibrahim Y; Grant, Marianne K O; El-Sawaf, Engie S; Zordoky, Beshay N.
Afiliação
  • Dabour MS; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA; Department of Clinical Pharmacy, Faculty of Pharmacy, Tanta University, 31111 Tanta, Egypt.
  • Abdelgawad IY; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
  • Grant MKO; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
  • El-Sawaf ES; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA; Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt.
  • Zordoky BN; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: zordo001@umn.edu.
Biomed Pharmacother ; 164: 114907, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37247463

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canagliflozina / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canagliflozina / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito